SCNI
Scinai Immunotherapeutics
SCNI
SCNI
2 hedge funds and large institutions have $126K invested in Scinai Immunotherapeutics in 2015 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 3 closing their positions.
Holders
2
Holders Change
-3
Holders Change %
-60%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
1
Jane Street
New York
|
$0 |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$0 |
| 3 |
3
Citigroup
New York
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
VIA
1
Vantage Investment Advisors
State College,
Pennsylvania
| $67K | – | – | – |
|
2
Bank of Montreal
Toronto,
Ontario, Canada
| $59K | – | – | – |
|
|
3
Jane Street
New York
| – | -$46K | -124 | Closed |
|
|
4
UBS Group
Zurich,
Switzerland
| – | -$13K | -35 | Closed |
|
|
5
Citigroup
New York
| – | -$1K | -3 | Closed |
|